Re‐irradiation of canine non‐lymphomatous nasal tumours using stereotactic radiation therapy (10 Gy x 3) for both courses: Assessment of outcome and toxicity in 11 dogs-Reference-Cited by-同舟云学术

Re‐irradiation of canine non‐lymphomatous nasal tumours using stereotactic radiation therapy (10 Gy x 3) for both courses: Assessment of outcome and toxicity in 11 dogs

Published:2022-02-13 Issue:2 Volume:20 Page:502-508
ISSN:1476-5810
Container-title:Veterinary and Comparative Oncology
language:en
Short-container-title:Vet Comparative Oncology

Author:

Gieger Tracy L.¹²,Haney Siobhan M.³,Nolan Michael W.¹²⁴^ORCID

Affiliation:

1. Department of Clinical Sciences College of Veterinary Medicine, North Carolina State University Raleigh North Carolina USA

2. Comparative Medicine Institute North Carolina State University Raleigh North Carolina USA

3. Hope Veterinary Specialists and the Veterinary CyberKnife Cancer Center Malvern Pennsylvania USA

4. Duke Cancer Institute Duke University Durham North Carolina USA

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vco.12801

Reference26 articles.

1. Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993–2003)

2. Canine intranasal tumours treated with alternating carboplatin and doxorubin in conjunction with oral piroxicam: 29 cases

3. Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours

4. REIRRADIATION OF RECURRENT CANINE NASAL TUMORS

5. Re-irradiation with stereotactic body radiation therapy (SBRT)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update in Veterinary Radiation Oncology;Veterinary Clinics of North America: Small Animal Practice;2023-12

2. Stereotactic radiotherapy (10 Gy X 3) for canine nonlymphomatous intranasal tumors is associated with prolonged survival and minimal risk of severe radiotoxicity;Journal of the American Veterinary Medical Association;2022-06-22